XML 14 R2.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Jun. 30, 2022
Dec. 31, 2021
Current assets    
Cash and cash equivalents $ 39,442 $ 37,187
Short-term investments 144,930 102,614
Accounts receivable, net 68,081 68,828
Inventory 47,007 40,410
Licensing receivable 0 90,000
Prepaid expenses and other current assets 11,950 16,611
Total current assets 311,410 355,650
Property, plant, and equipment, net 50,829 51,472
Operating lease right-of-use assets 21,560 22,669
Other assets 1,541 1,600
Total assets 385,340 431,391
Current liabilities    
Accounts payable 9,279 8,285
Accrued expenses and other current liabilities 105,639 112,341
Operating lease liabilities 4,744 4,365
Total current liabilities 119,662 124,991
Convertible notes, net 312,130 234,527
Deferred revenue, non-current 70,438 64,315
Operating lease liabilities, non-current 20,420 21,751
Other non-current liabilities 3,824 3,140
Total liabilities 526,474 448,724
Commitments and contingencies (Note 12)
Stockholders’ deficit    
Preferred stock, $0.001 par value; 15,000,000 shares authorized as of June 30, 2022 and December 31, 2021; none issued and outstanding 0 0
Common stock, $0.001 par value; 150,000,000 shares authorized as of June 30, 2022 and December 31, 2021; 48,686,248 and 48,444,473 shares issued and outstanding as of June 30, 2022 and December 31, 2021, respectively 48 48
Additional paid-in capital 1,020,822 1,136,656
Accumulated other comprehensive loss (793) (126)
Accumulated deficit (1,161,211) (1,153,911)
Total stockholders’ deficit (141,134) (17,333)
Total liabilities and stockholders’ deficit $ 385,340 $ 431,391